Agenda
June 18th, 2024
10:00-11:30 am
EAACI symposium title: Immune responses at the barrier sites through the lenses of new nomenclature of allergy and clinical immunology
Symposium Objective: To inform the audience about the newest discoveries in innate and adaptive immune responses at the barrier sites in allergic diseases of the skin and airways, using recently published allergy and clinical immunology nomenclature.
Chair: Milena Sokolowska, EAACI Basic and Clinical Immunology Section Chair, Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland
Organized by: Federation of Clinical Immunology Societies (FOCIS)-European Academy of Allergy and Clinical Immunology (EAACI)
10:00-10:15
Novel nomenclature of allergic diseases and hypersensitivity reactions. Marek Jutel, Medical University of Wroclaw, Wroclaw, Poland (12.5 min talk + 2.5 min discussion)
10:15-10:45
Autoimmunity in allergic and non-allergic skin diseases. Inge Kortekaas Krohn, Vrije Universiteit Brussel, Brussels, Belgium (25 talk+5 min discussion)
10:45-11:15
Crosstalk between allergic and viral-induced inflammation in asthma. Milena Sokolowska, Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland (25 talk+5 min discussion)
11:15-11:30 New EAACI Nomenclature: from bench to the clinic. Ioana Agache, Faculty of Medicine, Transylvania University, Brasov, Romania (12.5 min talk + 2.5 min discussion)
E-mails:
Marek Jutel: marek.jutel@all-med.wroclaw.pl
Inge Kortekaas Krohn: inge.kortekaas@vub.be
Milena Sokolowska: milena.sokolowska@siaf.uzh.ch
Ioana Agache: ibrumaru@unitbv.ro
1:30-3:00pm
EMBRN symposium title: Advances in mast cell research
Symposium objective: To highlight conceptual and technical innovations in mast cell research.
Chair: Adrian M. Piliponsky, University of Washington, Seattle, WA. USA.
Organized by: Federation of Clinical Immunology Societies (FOCIS)-European Mast cell and Basophil Research Network (EMBRN) Symposium
1:30 PM
Opening
1:35 PM
The allergic effector unit and the mast cells as masterminds from inflammation to its resolution: Have we found new druggable targets? Francesca Levi-Schaffer, PharmD, PhD, The Hebrew University of Jerusalem, Israel.
2:00 PM
How do mast cells build themselves? New insights and approaches to investigate the formation of mast cell granules and mediator storage. Adrian M. Piliponsky, PhD, University of Washington, Seattle, WA. USA.
1:25 PM
Modulation of Mast Cell Granule Composition by the Skin Environment. Anna Di Nardo, MD, PhD, University of California San Diego, CA, USA, and Experimental Laboratory of Cutaneous Physiopathology San Gallicano (IRCCS), San Gallicano, Rome, Italy.
2:50 PM
Closing Discussion and Questions for the Panel
E-mails:
Francesca Levi-Schaffer: francescal@ekmd.huji.ac.il
Adrian M. Piliponsky: adrian.piliponsky@seattlechildrens.org
Anna Di Nardo: adinardo4@gmail.com